American Joint Replacement Registry Releases 10th Annual Report

The American Joint Replacement Registry (AJRR), the cornerstone of the American Academy of Orthopaedic Surgeons (AAOS) Registry Program, published its 2023 Annual Report on hip and knee arthroplasty procedural trends and patient outcomes today.

Moffitt Researchers Develop Tool to Measure Patient Health and Well-Being after Radionuclide Therapy

Moffitt Cancer Center researchers have developed a tool to determine how a new class of prostate cancer therapies called radionuclide therapy (RNT) impacts patient-reported outcomes with the goal of using this information to guide treatment and improve quality of care. Their findings have been published in The Journal of Nuclear Medicine.

Orthopaedic surgeons available to speak about cartilage restoration of the knee in high-level athletes; factors that influence return to play

ROSEMONT, Ill. (October 28, 2021)—Articular cartilage injuries of the knee are being observed with increasing frequency in athletes, causing significant debilitation that threatens the ability to participate in sports. What’s more, these injuries have proven to be difficult to treat given the…

American Joint Replacement Registry Releases 2020 Annual Report

The American Joint Replacement Registry, the cornerstone of the American Academy of Orthopaedic Surgeons Registry Program, released its 2020 Annual Report on hip and knee arthroplasty patient outcomes. AJRR is the largest orthopaedic registry in the world based on annual procedures submitted, and the analysis provides insight into U.S. hip and knee arthroplasty practice.

Closing Gaps in Perspective of Value between Cancer Patients and their Health Care Providers

NCCN hosted an annual NCCN Patient Advocacy Summit: Delivering Value for Patients across the Oncology Ecosystem in Washington, DC, bringing together patients, advocates, clinicians, policy-makers, and others to share diverse perspectives on the meaning of value in cancer care.